Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025)
Historic Shares Outstanding for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $42.9 million.
- Dianthus Therapeutics' Shares Outstanding rose 4593.08% to $42.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year increase of 4593.08%. This contributed to the annual value of $31.1 million for FY2024, which is 10998.77% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Shares Outstanding of $42.9 million as of Q3 2025, which was up 4593.08% from $32.2 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Shares Outstanding ranged from a high of $42.9 million in Q3 2025 and a low of $10.3 million during Q1 2022
- Its 4-year average for Shares Outstanding is $28.9 million, with a median of $32.1 million in 2025.
- Data for Dianthus Therapeutics' Shares Outstanding shows a peak YoY increase of 22273.62% (in 2023) and a maximum YoY decrease of 5555.08% (in 2023) over the last 5 years.
- Over the past 4 years, Dianthus Therapeutics' Shares Outstanding (Quarter) stood at $33.3 million in 2022, then plummeted by 55.55% to $14.8 million in 2023, then surged by 109.99% to $31.1 million in 2024, then soared by 37.73% to $42.9 million in 2025.
- Its last three reported values are $42.9 million in Q3 2025, $32.2 million for Q2 2025, and $32.1 million during Q1 2025.